These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2179362)

  • 21. Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
    Poole JE; Werner JA; Bardy GH; Graham EL; Pulaski WP; Fahrenbruch CE; Greene HL
    Am Heart J; 1986 Aug; 112(2):322-6. PubMed ID: 3739884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mexiletine and quinidine in combination in an ischemic model: supra-additive antiarrhythmic and electrophysiologic actions.
    Duff HJ; Gault NJ
    J Cardiovasc Pharmacol; 1986; 8(4):847-57. PubMed ID: 2427828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of mexiletine and dihydroquinidine in the treatment of ventricular asystolic arrhythmia].
    Accettura D; De Toma L; Lagioia R; Mastropasqua F; Mangini SG; Scrutinio D; Rizzon P
    Cardiologia; 1985 Feb; 30(2):107-12. PubMed ID: 2415255
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effectiveness of a combination of mexitil with etmozin, allapinin or quinidine in ventricular extrasystole].
    Abdalla A; Mazur NA
    Klin Med (Mosk); 1988 May; 66(5):57-60. PubMed ID: 2458502
    [No Abstract]   [Full Text] [Related]  

  • 25. Mexiletine-quinidine combination: enhanced antiarrhythmic and electrophysiologic activity in the dog.
    Duff HJ
    J Pharmacol Exp Ther; 1989 May; 249(2):617-22. PubMed ID: 2724143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mexiletine-quinidine in isolated hearts: an interaction involving the sodium channel.
    Duff HJ; Cannon NJ; Sheldon RS
    Cardiovasc Res; 1989 Jul; 23(7):584-92. PubMed ID: 2557155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia.
    Patt MV; Grossbard CL; Graboys TB; Lown B
    Am J Cardiol; 1988 Nov; 62(14):18I-21I. PubMed ID: 2461071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conversion from intravenous to oral mexiletine in the acute management of repetitive ventricular arrhythmia.
    Horowitz LN; Greenspan AM; Spielman SR; Frye SJ; Yacone LA; Lowenthal DT
    Clin Pharmacol Ther; 1985 Jun; 37(6):644-8. PubMed ID: 2408808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quinidine for ventricular arrhythmias: value of electrophysiologic testing.
    DiMarco JP; Garan H; Ruskin JN
    Am J Cardiol; 1983 Jan; 51(1):90-5. PubMed ID: 6849270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-arrhythmia effectiveness and tolerance of retard in comparison with standard mexiletine].
    Zehender M; Geibel A; Hust M; Hohnloser S; Meinertz T; Just H
    Z Kardiol; 1987 Aug; 76(8):501-6. PubMed ID: 2445118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effect of mexiletine on left ventricular function and relation to suppression of ventricular arrhythmia.
    Singh S; Klein R; Eisenberg B; Hughes E; Shand M; Doherty P
    Am J Cardiol; 1990 Nov; 66(17):1222-7. PubMed ID: 1700592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
    Whitford EG; McGovern B; Schoenfeld MH; Garan H; Newell JB; McElroy M; Ruskin JN
    Am Heart J; 1988 Feb; 115(2):360-6. PubMed ID: 3341170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.
    Monk JP; Brogden RN
    Drugs; 1990 Sep; 40(3):374-411. PubMed ID: 2226221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias.
    Morganroth J; Somberg JC; Pool PE; Hsu PH; Lee IK; Durkee J; Salerno DM
    J Am Coll Cardiol; 1986 Jan; 7(1):9-16. PubMed ID: 3079781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crossover comparison of cibenzoline and quinidine in ambulatory patients with chronic ventricular arrhythmias.
    Mohiuddin SM; Woodruff MP; Esterbrooks DJ; Mooss AN; Hansen JM; Hilleman DE
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):525-9. PubMed ID: 2470988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mexiletine for refractory-ventricular arrhythmias: results using serial electrophysiologic testing.
    DiMarco JP; Garan H; Ruskin JN
    Am J Cardiol; 1981 Jan; 47(1):131-8. PubMed ID: 7457398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of procainamide and quinidine for better tolerance and additive effects for ventricular arrhythmias.
    Kim SG; Seiden SW; Matos JA; Waspe LE; Fisher JD
    Am J Cardiol; 1985 Jul; 56(1):84-8. PubMed ID: 4014046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of mexiletine in chronic ventricular arrhythmias: a multicentre double-blind medium-term trial.
    Poggesi L; Scarti L; Ieri A; Lanzetta T; Grazzini M; Del Bene P; Masini G; Del Citerna F; Carnovali M; Masotti G
    Int J Clin Pharmacol Res; 1989; 9(4):269-75. PubMed ID: 2476406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of combination therapy with mexiletine and a low dose of propranolol for premature ventricular arrhythmias.
    Kobayashi A; Yamazaki N; Kobayashi T; Watanabe T; Ito T; Ogawa K
    Jpn Circ J; 1990 Dec; 54(12):1486-96. PubMed ID: 2077145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mexiletine, a new antiarrhythmic agent, for treatment of premature ventricular complexes.
    Mehta J; Conti CR
    Am J Cardiol; 1982 Feb; 49(2):455-60. PubMed ID: 6174042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.